GRI Bio, Inc. (GRI)

GRI Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-8.26	-13.04	-3.22	-1.56	-2.53
Depreciation & Amortization	-0.1	0.06	0.05	0.05	0.06
Other Amortization	-	2.1	0.22	0.15	0.71
Stock-Based Compensation	0.15	0.39	0.03	-	0.28
Other Operating Activities	-0.2	-0.18	0.33	-0.05	-
Change in Accounts Payable	-2.85	2.16	0.9	0.05	-0.03
Change in Other Net Operating Assets	-0.91	-0.48	0.62	0.51	0.68
Operating Cash Flow	-12.17	-8.99	-1.09	-0.85	-0.83
Capital Expenditures	-	-0.01	-0	-	-
Investing Cash Flow	-	-0.01	-0	-	-
Short-Term Debt Issued	-	13.69	1.54	0.5	0.25
Total Debt Issued	12.25	13.69	1.54	0.5	0.25
Short-Term Debt Repaid	-	-0.2	-0.28	-	-
Total Debt Repaid	-	-0.2	-0.28	-	-
Net Debt Issued (Repaid)	12.25	13.5	1.26	0.5	0.25
Issuance of Common Stock	-	0.01	-	0.1	0.5
Repurchase of Common Stock	-0.76	-	-0.12	-	-
Other Financing Activities	1.94	-2.71	-0.12	-	-
Financing Cash Flow	13.43	10.8	1.01	0.6	0.75
Net Cash Flow	1.26	1.8	-0.08	-0.25	-0.08
Free Cash Flow	-12.17	-9	-1.09	-0.85	-0.83
Free Cash Flow Per Share	-11.63	-253.43	-	-3.23	-3.24
Cash Interest Paid	-	-	0.03	-	0
Levered Free Cash Flow	-6.23	-5.2	-1.81	-1.61	-
Unlevered Free Cash Flow	-4.93	-6	-1.62	-1.42	-
Change in Net Working Capital	0.18	-0.53	0.29	0.8	-

Source: S&P Capital IQ. Standard template. Financial Sources.